Welcome!

The Division of Cellular and Molecular Therapy consists of a group of investigators having shared interests in both basic molecular biology of AAV, and the development of next generation of AAV vectors, eminently suitable for human gene therapy. It also serves as a reference point for collating the in-flow and out-flow of ideas and materials relevant to application of AAV vectors in basic science research and clinical trials on campus as well as elsewhere throughout the scientific community.

Research

Research Labs

The Pediatric Division of Cellular and Molecular Therapy houses three laboratories. The Arun Srivastava Lab, the Sergei Zolotukhin Lab, and the Brad Hoffman Lab. Dr. Srivastava's and Dr. Hoffman's research groups are developing gene immunotherapy to treat autoimmune diseases using the AAV gene therapy platform.

person holding laboratory flask

UF Pediatric News

A “twindemic”: 2020-21 flu season may be deadly alongside COVID-19, experts warn

AavantiBio Launches With $107 Million Series A Financing

UF Health professor part of prestigious national committee advising on COVID-19 vaccine allocation

A beacon of hope